巴基斯坦电子烟和尼古丁袋用于戒烟的临床研究方案:一项随机对照试验
该方案计划在巴基斯坦纳入600名成年吸烟者,随机分为电子烟加基础护理咨询组、尼古丁袋加基础护理咨询组和仅基础护理咨询组,每组200人,干预期48周,每12周随访一次,采用双变量和多变量分析及准实验方法评估戒烟效果。
要点
- 600名参与者分三组,每组200人,干预48周,每12周随访。
- 采用双变量和多变量分析及倍差法或倾向评分匹配评估效果。
核心结论
- 该研究方案旨在评估电子烟和尼古丁袋作为戒烟辅助手段在巴基斯坦的有效性,结果预计将为公众、决策者和研究人员提供短期和中期使用效果的信息。
研究设计与样本
- 随机对照试验方案,计划样本量600名参与者,分为三组每组200人,干预48周,每12周随访一次。
主要发现
- 原文未报告结果,因为试验尚在进行中且尚未招募参与者,预计主要数据收集日期为2024年4月。
关键数值与推荐
- 200名参与者接受电子烟加基础护理咨询,200名接受尼古丁袋加基础护理咨询,剩余200名仅接受基础护理咨询,持续48周。
- 使用简单t检验和方差分析评估干预指标在对照组和治疗组之间的差异。
- 平均治疗效应基于倍差法或倾向评分匹配等准实验技术进行推断分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pakistan is one of most vulnerable low- and middle-income countries with 29 million adult active tobacco users. Smoking cessation services are lacking as the tobacco control initiatives have largely failed to address the smoking endemic. Over the last 5 years, Pakistan has witnessed the use of innovative tobacco harm reduction (THR) products such as e-cigarettes and nicotine pouches. However, their use remains limited. THR products are imported legally as consumer goods and are taxable. The lack of sufficient data for THR and its application is a challenge in gauging their effectiveness in assisting smokers quit combustible smoking. Evidence-based studies can help in measuring the effectiveness of e-cigarettes and nicotine pouches as smoking cessation aids. METHOD: Keeping in view the study objectives, a sample size of 600 participants will be sufficient to assess the effectiveness of e-cigarettes and nicotine pouches for smoking cessation in Pakistan. Of these, 200 participants each will receive e-cigarettes and nicotine pouches along with basic care counselling, while the remaining 200 participants will only receive basic care counselling for 48 weeks. The association of participants' characteristics with smoking and health status will be based on the bivariate and multivariate analysis. The simple t-test and variance analysis will assess the differences in intervention indicators between the control and treatment groups. For the inferential analysis, the average treatment impact will be based on the quasi-experimental techniques such as difference in difference (DID) or propensity score matching (PMS). DISCUSSION: The study will evaluate the participants at the baseline as they decide the quit date. After every 12 weeks, a follow-up survey with the participants will be conducted. Results are anticipated to inform the public, decision-makers, and researchers about the effects of using e-cigarettes and nicotine pouches in the short- and medium-term periods. Critically, the potential of e-cigarettes and other alternative nicotine delivery systems as smoking cessation aid will be assessed. TRIAL REGISTRATION: ClinicalTrials.gov NCT05715164 . Registered on February 6, 2023. PROTOCOL VERSION: Protocol version 1.0, 14-12-2022 Trial in progress and not yet recruiting participants. Estimated primary data collection date-April 2024.
引用
- Hameed A, Malik D. Clinical study protocol on electronic cigarettes and nicotine pouches for smoking cessation in Pakistan: a randomized controlled trial. Trials. 2024. PMID: 38167206. doi:10.1186/s13063-023-07876-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。